Skip to main content

previous disabled Page of 5
and
  1. Article

    Open Access

    Long-term responders to nivolumab in previously treated advanced renal cell carcinoma: a sub-analysis of meet-URO15 study

    Although nivolumab prolongs overall survival (OS) in pretreated patients with metastatic renal cell carcinoma (mRCC), underlining clinical and biological features of long-term responses are still to be determi...

    Carlo Messina, Martina Catalano, Giandomenico Roviello in Cancer Immunology, Immunotherapy (2024)

  2. Article

    Open Access

    Characterization of two transcriptomic subtypes of marker-null large cell carcinoma of the lung suggests different origin and potential new therapeutic perspectives

    Pulmonary large cell carcinoma (LCC) is an undifferentiated neoplasm lacking morphological, histochemical, and immunohistochemical features of small cell lung cancer, adenocarcinoma (ADC), or squamous cell car...

    Michele Simbolo, Giovanni Centonze, Anastasios Gkountakos in Virchows Archiv (2024)

  3. Article

    Open Access

    Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study

    Immune checkpoint inhibitors have changed previous treatment paradigm of advanced urothelial carcinoma (UC). The ARON-2 study (NCT05290038) aimed to assess the real-world effectiveness of pembrolizumab in pati...

    Francesco Massari, Matteo Santoni, Hideki Takeshita in Cancer Immunology, Immunotherapy (2024)

  4. Article

    Open Access

    Author Correction: Metformin-induced ablation of microRNA 21-5p releases Sestrin-1 and CAB39L antitumoral activities

    Claudio Pulito, Federica Mori, Andrea Sacconi, Frauke Goeman in Cell Discovery (2024)

  5. Article

    Open Access

    The endocrine disruptor cadmium modulates the androgen–estrogen receptors ratio and induces inflammatory cytokines in luminal (A) cell models of breast cancer

    Breast cancer (BC) is the most common malignancy that affects women, and it is, to date, their leading cause of death. Luminal A molecular subtype accounts for 40% of BC and is characterized by hormone recepto...

    Viviana M. Bimonte, Giuseppina Catanzaro, Agnese Po, Sofia Trocchianesi in Endocrine (2024)

  6. No Access

    Article

    Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes

    The clinical outcome and the efficacy of chemotherapy in pancreatic cancer patients with BRCA1/2 Variants of Unknown Significance (VUS) is unknown. We explored the effects of chemotherapy with or without Plati...

    Anna Maria Militello, Giulia Orsi in Cancer Chemotherapy and Pharmacology (2023)

  7. Article

    Open Access

    Effect of exercise across the head and neck cancer continuum: a systematic review of randomized controlled trials

    This study aims to systematically explore the impact of physical exercise as supportive therapy for head and neck cancer.

    Alice Avancini, Anita Borsati, Lorenzo Belluomini in Supportive Care in Cancer (2023)

  8. Article

    Open Access

    Leptin-mediated meta-inflammation may provide survival benefit in patients receiving maintenance immunotherapy for extensive-stage small cell lung cancer (ES-SCLC)

    Only few ES-SCLC patients experience long-term survival benefit by maintenance IT. Adipokines-induced metabolic meta-inflammation has been related to enhanced responsiveness to IT in obese patients; however, t...

    Emanuele Vita, Alessio Stefani, Geny Piro in Cancer Immunology, Immunotherapy (2023)

  9. No Access

    Article

    Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study

    Concomitant medications may potentially affect the outcome of cancer patients. In this sub-analysis of the ARON-2 real-world study (NCT05290038), we aimed to assess the impact of concomitant use of proton pump...

    Ondřej Fiala, Sebastiano Buti, Hideki Takeshita in Cancer Immunology, Immunotherapy (2023)

  10. No Access

    Article

    Recurrent gastric amphicrine tumor with neuroendocrine and pancreatic acinar cell differentiation and somatic MEN1 inactivation arisen during immunotherapy

    Amphicrine neoplasms (ANs) are poorly understood epithelial malignancies composed of cells with co-existing exocrine-neuroendocrine features. Here, we report a recurrent mucin-producing gastric amphicrine tumo...

    Maria G. Mastrosimini, Andrea Mafficini, Luca Tondulli, Michele Milella in Virchows Archiv (2023)

  11. Article

    Open Access

    A qualitative study exploring the experiences and perspectives of patients with cancer attending a 12-week exercise program

    Physical activity is associated with a reduction in mortality and recurrence risks in patients with cancer. Despite the well-recognized benefits of exercise, patients’ adherence to an exercise program remains ...

    Anita Borsati, Angela Marotta, Valentina Ducoli in Sport Sciences for Health (2023)

  12. Article

    Open Access

    Willingness, preferences, barriers, and facilitators of a multimodal supportive care intervention including exercise, nutritional and psychological approach in patients with cancer: a cross-sectional study

    Supportive care, including exercise, nutritional and psychological support, is becoming increasingly important in cancer given their impact on ‘patients’ quality and quantity of life. The purpose of this study...

    Alice Avancini, Ilaria Trestini in Journal of Cancer Research and Clinical On… (2023)

  13. No Access

    Article

    Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv)

    Pancreatic ductal adenocarcinoma (PDAC) harbouring germline BRCA1-2 pathogenic variants (gBRCA1-2pv) is a distinct nosological entity. Information on second-line therapy (2LT) outcome in this setting is lacking.

    Giulia Orsi, Alessandro Cavaliere, Giampaolo Tortora in British Journal of Cancer (2023)

  14. Article

    Open Access

    Development of Educational Print Materials for Physical Activity in Cancer: Evaluation of Readability and Suitability

    Educational health materials may be important tools to increase physical activity in cancer patients. Nevertheless, most of the available resources regarding physical activity for cancer patients were found no...

    Alice Avancini, Giulia Benato, Daniela Tregnago in Journal of Cancer Education (2023)

  15. No Access

    Article

    Exercise in men with prostate cancer: how to move on?

    Alice Avancini, Lorenzo Belluomini, Daniela Tregnago in Supportive Care in Cancer (2022)

  16. Article

    Open Access

    Multicentre, randomised, open-label, parallel-group, clinical phase II study to evaluate immunonutrition in improving efficacy of immunotherapy in patients with metastatic non-small cell lung cancer, undergoing systematic nutritional counseling

    Nutritional support, including nutritional counseling and oral nutritional supplements (ONS), has been recommended as a first-line strategy in patients with non-small cell lung cancer (NSCLC). Evidence on the ...

    Riccardo Caccialanza, Emanuele Cereda, Francesco Agustoni, Catherine Klersy in BMC Cancer (2022)

  17. Article

    Open Access

    The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study

    Nephrectomy is considered the backbone of managing patients with localized and selected metastatic renal cell carcinoma (mRCC). The prognostic role of nephrectomy has been widely investigated with cytokines an...

    Sara Elena Rebuzzi, Alessio Signori in Journal of Translational Medicine (2022)

  18. Article

    Open Access

    Loss of FGFR4 promotes the malignant phenotype of PDAC

    Transcriptomic analyses of pancreatic ductal adenocarcinoma (PDAC) have identified two major epithelial subtypes with distinct biology and clinical behaviours. Here, we aimed to clarify the role of FGFR1 and F...

    Sabrina D’Agosto, Francesco Pezzini, Lisa Veghini, Pietro Delfino in Oncogene (2022)

  19. Article

    Open Access

    “Pure” hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms

    Hepatoid tumors (HTs) represent a rare group of neoplasms that are histologically similar to hepatocellular carcinoma but arise outside the liver. The current World Health Organization classification recognize...

    Paola Mattiolo, Andrea Mafficini, Rita T. Lawlor, Giovanni Marchegiani in Virchows Archiv (2022)

  20. No Access

    Article

    Histo-molecular characterization of pancreatic cancer with microsatellite instability: intra-tumor heterogeneity, B2M inactivation, and the importance of metastatic sites

    Pancreatic ductal adenocarcinoma (PDAC) with microsatellite instability (MSI)/defective mismatch repair (dMMR) is the only subtype of pancreatic cancer with potential response to immunotherapy. Here, we report...

    Claudio Luchini, Andrea Mafficini, Deyali Chatterjee, Maria L. Piredda in Virchows Archiv (2022)

previous disabled Page of 5